There is no dengue vaccine for humans. But in two papers published in the Aug. 25, 2011, edition of Nature, Australian scientists reported that they can essentially vaccinate mosquitoes against the dengue virus by infecting them with another microbe: the bacterium Wolbachia. Read More
A landmark compilation of start-up companies and scientific advances paving the way in emerging biotech markets, BioWorld's Innovations in Biotechnology 2011: New Science, Emerging Companies, Rising Stars is a must-have! Read More
Oxygen Biotherapeutics Inc., of Morrisville, N.C., dismissed Chris Stern as CEO and chairman of the company, following an internal investigation. Although the circumstances related to the dismissal were not disclosed, the company said Stern will not be paid severance. Michael Jebsen was named interim CEO as he continues serving as chief financial officer and treasurer. Read More
Bionor Pharma ASA, of Oslo, Norway, said it plans to conduct an exploratory study of its HIV vaccine candidate, Vacc-4x, in combination with Revlimid (lenalidomide, Celgene Corp.). Read More
Shire Human Genetic Therapies (HGT) is getting social as it launches its newly approved Firazyr, a self-administered injectable treatment for acute attacks of hereditary angioedema (HAE) in adults. Read More
Only two months after Shire plc shelled out $750 million in cash for Advanced BioHealing Inc. – a move hailed as a rare win for investors in the regenerative medicine space – the big pharma reported disappointing data from a pivotal trial aimed at expanding the use of ABH's lead product Dermagraft. Read More
